Mangalam Drugs & Organics Limited (NSE:MANGALAM)
28.35
+0.55 (1.98%)
Apr 28, 2026, 3:15 PM IST
Revenue by Segment
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Source: S&P Global Market Intelligence.